BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ayyar VS, Jusko WJ. Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids. Pharmacol Rev 2020;72:414-38. [PMID: 32123034 DOI: 10.1124/pr.119.018101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Cui Y, Sun Y, Sun J, Liang H, Ding X, Sun X, Wang D, Sun T. Efficacy and Safety of Corticosteroid Use in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis. Infect Dis Ther 2021. [PMID: 34389970 DOI: 10.1007/s40121-021-00518-3] [Reference Citation Analysis]
2 Ayyar VS, Sukumaran S. Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions. J Pharmacokinet Pharmacodyn 2021;48:321-38. [PMID: 33797011 DOI: 10.1007/s10928-021-09751-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhou Z, Zhu J, Jiang M, Sang L, Hao K, He H. The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development. Pharmaceutics 2021;13:704. [PMID: 34065907 DOI: 10.3390/pharmaceutics13050704] [Reference Citation Analysis]
4 Choi YH, Zhang C, Liu Z, Tu MJ, Yu AX, Yu AM. A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism. J Pharmacol Exp Ther 2021;377:305-15. [PMID: 33712506 DOI: 10.1124/jpet.121.000584] [Reference Citation Analysis]
5 van Saet A, Zeilmaker-Roest GA, Stolker RJ, Bogers AJJC, Tibboel D. Methylprednisolone in Pediatric Cardiac Surgery: Is There Enough Evidence? Front Cardiovasc Med 2021;8:730157. [PMID: 34631828 DOI: 10.3389/fcvm.2021.730157] [Reference Citation Analysis]
6 Ayyar VS, Lee JB, Wang W, Pryor M, Zhuang Y, Wilde T, Vermeulen A. Minimal Physiologically-Based Pharmacokinetic (mPBPK) Metamodeling of Target Engagement in Skin Informs Anti-IL17A Drug Development in Psoriasis. Front Pharmacol 2022;13:862291. [PMID: 35548359 DOI: 10.3389/fphar.2022.862291] [Reference Citation Analysis]
7 Meduri GU, Annane D, Confalonieri M, Chrousos GP, Rochwerg B, Busby A, Ruaro B, Meibohm B. Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS. Intensive Care Med 2020;46:2284-96. [PMID: 33150472 DOI: 10.1007/s00134-020-06289-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
8 Ko JJ, Wu C, Mehta N, Wald-Dickler N, Yang W, Qiao R. A Comparison of Methylprednisolone and Dexamethasone in Intensive Care Patients With COVID-19. J Intensive Care Med 2021;36:673-80. [PMID: 33632000 DOI: 10.1177/0885066621994057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
9 Mavroudis PD, Jusko WJ. Mathematical modeling of mammalian circadian clocks affecting drug and disease responses. J Pharmacokinet Pharmacodyn 2021;48:375-86. [PMID: 33725238 DOI: 10.1007/s10928-021-09746-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ayyar VS, Song D, Zheng S, Carpenter T, Heald DL. Minimal physiologically based pharmacokinetic-pharmacodynamic (mPBPK-PD) model of GalNAc-conjugated siRNA disposition and gene silencing in preclinical species and humans. J Pharmacol Exp Ther 2021:JPET-AR-2021-000805. [PMID: 34413198 DOI: 10.1124/jpet.121.000805] [Reference Citation Analysis]